美國IBIS Biosciences  www.ibisbiosciences.com www.isispharm.com  www.abbott.com
Isis的Ibis T5000生物傳感器系統(tǒng)，該系統(tǒng)是一個(gè)能夠檢測傳染原的研究設(shè)備，尤其是，其能夠檢測醫(yī)院獲得性感染.
雅培2.15億美元收購Isis子公司——Ibis Biosciences Inc 

Ibis Biosciences, Inc., a majority-owned subsidiary of Isis Pharmaceuticals, has developed and is commercializing the Ibis T5000(TM) Biosensor System for rapid identification and characterization of infectious agents. The Ibis T5000 is currently intended for research use only and not for use in diagnostic procedures. It is capable of identifying virtually all bacteria, viruses and fungi, and can provide information about drug resistance, virulence and strain type of these pathogens. Commercial applications for the Ibis T5000 Biosensor System include epidemiologic surveillance, monitoring of pandemic diseases, identification of emerging or previously unknown pathogens, forensic characterization of human samples, identification of sources of hospital-associated infections, and, in the future, human infectious disease diagnostics. Ibis develops, manufactures and markets Ibis T5000 instruments and assay kits. 
The Ibis T5000? Biosensor System, a hardware platform, and accompanying research assay kits, have the potential to revolutionize the identification of infectious diseases. Ibis Biosciences employs a unique solution for the identification of biological organisms, including bacteria, viruses, fungi, and protozoa. It is also a powerful tool for human forensics.
Traditional technology is typically limited to testing for the presence of a single organism or small set of organisms. If the expected organism is not detected, additional tests are required to identify what organism or organisms may be present. The Ibis T5000 Biosensor System overcomes these limitations.
The wide range of prospective applications of the Ibis T5000 Biosensor System include areas such as national security, healthcare infection management, and forensics.
The Ibis T5000 Biosensor System features an integrated workflow and gives users an end-to-end solution requiring less than five hours from sample to answers. Just as important, the simple user interface enables system operation and interpretation of results without specialized expertise.